Concurrent adjuvant radiotherapy and interferon-alpha2b for resected high risk stage III melanoma - a retrospective single centre study. - Gyorki,D.E.; Ainslie,J.; Joon,M.L.; Henderson,M.A.; Millward,M.; McArthur,G.A. (Melanoma Res, 2004)